-
-
Key words:
- intra-abdominal infection /
- sepsis /
- antibiotic /
- etiological control
-
[1] Shirah GR,O'Neill PJ.Intra-abdominal Infections[J].Surgical Clin North Am,2014,94(6):1319-1331.
[2] Klevens RM,Morrison MA,Nadle J,et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States[J].JAMA,2007,298(15):1763-1771.
[3] Solomkin JS,Mazuski JE,Bradley JS,et al.Diagnosis and management of complicated intra-abdominal infection in adults and children:guidelines by the Surgical Infection Society and the Infectious Diseases Society of America[J].Clin Infect Dis,2010,50(2):133-164.
[4] Mazuski JE,Tessier JM,May AK,et al.The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection[J].Surg Infect (Larchmt),2017,18(1):1-76.
[5] Lopez N,Kobayashi L,Coimbra R.A Comprehensive review of abdominal infections[J].World J Emerg Surg,2011,6(1):7.
[6] Pieracci FM,Barie PS.Management of severe sepsis of abdominal origin[J].Scandinavian J Surg:SJS,2007,96(3):184-196.
[7] Loganathan A.Intra-abdominal sepsis[J].Surgery (Oxford),2015,33(11):553-558.
[8] Sartelli M,Chichom-Mefire A,Labricciosa FM,et al.The management of intra-abdominal infections from a global perspective:2017 WSES guidelines for management of intra-abdominal infections[J].World J Emerg Surg,2017,12:29.
[9] Emmi V,Sganga G.Clinical diagnosis of intra-abdominal infections[J].J Chemoth,2009,21(Suppl 1):12-18.
[10] Watkins RR,Lemonovich TL.Serum procalcitonin in the diagnosis and management of intra-abdominal infections[J].Expert Rev Anti Infect Ther,2012,10(2):197-205.
[11] Eng KA,Abadeh A,Ligocki C,et al.Acute Appendicitis:A meta-Analysis of the Diagnostic Accuracy of US,CT,and MRI as Second-Line Imaging Tests after an Initial US[J].Radiology,2018,288(3):717-727.
[12] Crandall M,West MA.Evaluation of the abdomen in the critically ill patient:opening the black box[J].Current Opinion Crit Care,2006,12(4):333-339.
[13] Sartelli M,Catena F,Abu-Zidan FM,et al.Management of intra-abdominal infections:recommendations by the WSES 2016 consensus conference[J].World J Emerg Surg,2017,12:22.
[14] Montravers P,Dupont H,Leone M,et al.Guidelines for management of intra-abdominal infections[J].Anaesthesia Crit Care Pain Med,2015,34(2):117-130.
[15] Singer M,Deutschman CS,Seymour CW,et al.The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].JAMA,2016,315(8):801-810.
[16] Menichetti F,Sganga G.Definition and classification of intra-abdominal infections[J].J Chemotherapy,2009,21(Suppl 1):3-4.
[17] Billing A,Frohlich D,Schildberg FW.Prediction of outcome using the Mannheim peritonitis index in 2003 patients.Peritonitis Study Group[J].British J Surg,1994,81(2):209-213.
[18] Montravers P,Lepape A,Dubreuil L,et al.Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections:results of the French prospective,observational EBIIA study[J].J Antimicrobial Chemoth,2009,63(4):785-794.
[19] Levy MM,Evans LE,Rhodes A.The Surviving Sepsis Campaign Bundle:2018 Update[J].Crit Care Med,2018,46(6):997-1000.
[20] Marik P,Bellomo R.A rational approach to fluid therapy in sepsis[J].British J Anaesthesia,2016,116(3):339-349.
[21] Asfar P,Meziani F,Hamel JF,et al.High versus low blood-pressure target in patients with septic shock[J].New England J Med,2014,370(17):1583-1593.
[22] Hecker A,Schneck E,Rohrig R,et al.The impact of early surgical intervention in free intestinal perforation:a time-to-intervention pilot study[J].World J Emerg Surg,2015,10:54.
[23] Puskarich MA,Trzeciak S,Shapiro NI,et al.Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol[J].Crit Care Med,2011,39(9):2066-2071.
[24] Zhang S,Huang W.Epidemiological study of community-and hospital-acquired intraabdominal infections[J].Chinese J Traumatol,2015,18(2):84-89.
[25] Kurup A,Liau KH,Ren J,et al.Antibiotic management of complicated intra-abdominal infections in adults:The Asian perspective[J].Ann Med Surg,2014,3(3):85-91.
[26] Kiratisin P,Chongthaleong A,Tan TY,et al.Comparative in vitro activity of carbapenems against major Gram-negative pathogens:results of Asia-Pacific surveillance from the COMPACT II study[J].Int J Antimicrobial Agents,2012,39(4):311-316.
[27] Esposito S,Leone S,Carosi G.Analysis of current guidelines for intra-abdominal infections[J].J Chemotherapy,2009,21(Suppl 1):30-35.
计量
- 文章访问数: 237
- PDF下载数: 687
- 施引文献: 0